X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (881) 881
Patent (614) 614
Conference Proceeding (74) 74
Publication (39) 39
Magazine Article (11) 11
Book / eBook (6) 6
Dissertation (6) 6
Newspaper Article (3) 3
Book Chapter (1) 1
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (207) 207
physics (160) 160
humans (153) 153
chemistry (152) 152
metallurgy (142) 142
electricity (125) 125
performing operations (107) 107
transporting (107) 107
male (102) 102
human necessities (99) 99
animals (98) 98
general tagging of cross-sectional technologies spanning over several sections of the ipc (86) 86
general tagging of new technological developments (86) 86
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (86) 86
technologies or applications for mitigation or adaptation againstclimate change (86) 86
biochemistry (79) 79
microbiology (79) 79
testing (79) 79
measuring (78) 78
beer (69) 69
enzymology (69) 69
mutation or genetic engineering (69) 69
spirits (69) 69
vinegar (69) 69
wine (69) 69
female (66) 66
generation (66) 66
conversion or distribution of electric power (64) 64
analysis (56) 56
fixed constructions (53) 53
reduction of greenhouse gas [ghg] emissions, related to energygeneration, transmission or distribution (53) 53
middle aged (52) 52
hygiene (51) 51
medical or veterinary science (51) 51
mice (51) 51
lighting (47) 47
blasting (46) 46
heating (46) 46
mechanical engineering (46) 46
oncology (46) 46
weapons (46) 46
cancer (44) 44
adult (43) 43
apparatus for enzymology or microbiology (39) 39
cell line, tumor (39) 39
investigating or analysing materials by determining theirchemical or physical properties (39) 39
aged (38) 38
calculating (38) 38
computing (38) 38
counting (38) 38
proteins (37) 37
treatment of water, waste water, sewage, or sludge (37) 37
basic electric elements (36) 36
china (36) 36
agriculture (35) 35
apoptosis (35) 35
materials science, multidisciplinary (35) 35
animal husbandry (34) 34
circuit arrangements or systems for supplying or distributingelectric power (34) 34
fishing (34) 34
forestry (34) 34
hunting (34) 34
cell biology (33) 33
rats (33) 33
research (33) 33
systems for storing electric energy (33) 33
trapping (33) 33
expression (32) 32
gene expression (32) 32
health aspects (32) 32
diagnosis (31) 31
growth (31) 31
identification (31) 31
article (30) 30
biochemistry & molecular biology (29) 29
surgery (28) 28
multidisciplinary sciences (27) 27
nanoparticles (27) 27
studies (26) 26
electric communication technique (25) 25
organic chemistry (25) 25
climate change mitigation technologies related to wastewatertreatment or waste management (24) 24
physical or chemical processes or apparatus in general (24) 24
risk factors (24) 24
activation (23) 23
chemistry, multidisciplinary (23) 23
metabolism (23) 23
chemistry, physical (22) 22
genetic aspects (22) 22
mutation (22) 22
prostate cancer (22) 22
research article (22) 22
technologies for adaptation to climate change (22) 22
compositions or test papers therefor (21) 21
condition-responsive control in microbiological orenzymological processes (21) 21
electric digital data processing (21) 21
optics (21) 21
turbulence (21) 21
medicine (20) 20
phosphorylation (20) 20
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


04/2018, 1st ed. 2018, ISBN 3319779648, 187
With the growing popularity of "big data", the potential value of personal data has attracted more and more attention. Applications built on personal data can... 
Data structures (Computer science) | Data mining
eBook
Advances in Mechanics, ISSN 1000-0992, 08/2015, Volume 45, Issue 1, pp. 111 - 140
Journal Article
IEEE Transactions on Vehicular Technology, ISSN 0018-9545, 09/2019, Volume 68, Issue 9, pp. 9098 - 9109
Unmanned aerial vehicles (UAVs) may be used for providing seamless network coverage in urban areas for improving the performance of conventional cellular... 
Cloud computing | Analytical models | Unmanned aerial vehicle (UAV) | 5G mobile communication | Network slicing | Systems operation | seamless coverage | Mathematical model | Resource management | cyclic recharging and reshuffling strategy (CRRS)
Journal Article
IEEE Access, ISSN 2169-3536, 2014, Volume 2, pp. 1149 - 1176
Journal Article
Nature Biotechnology, ISSN 1087-0156, 05/2015, Volume 33, Issue 5, pp. 531 - 537
Journal Article
Nature, ISSN 0028-0836, 05/2016, Volume 534, Issue 7605, pp. 129 - 132
The epidermal growth factor receptor (EGFR)-directed tyrosine kinase inhibitors (TKIs) gefitinib, erlotinib and afatinib are approved treatments for non-small... 
CELL LUNG-CANCER | EGFR KINASE | GROWTH-FACTOR RECEPTOR | TARGETED THERAPIES | GEFITINIB | ACTIVATION | MECHANISM | MULTIDISCIPLINARY SCIENCES | MUTATIONS | AZD9291 | Lung Neoplasms - drug therapy | Drug Resistance, Multiple - drug effects | Protein Conformation - drug effects | ErbB Receptors - genetics | Lung Neoplasms - pathology | Antineoplastic Agents - pharmacology | Benzeneacetamides - pharmacology | Mutant Proteins - antagonists & inhibitors | Disease Models, Animal | Allosteric Regulation - drug effects | Carcinoma, Non-Small-Cell Lung - pathology | Drug Resistance, Multiple - genetics | ErbB Receptors - antagonists & inhibitors | ErbB Receptors - metabolism | Lung Neoplasms - enzymology | Allosteric Site - drug effects | Mutant Proteins - genetics | Cetuximab - pharmacology | Mutant Proteins - metabolism | Drug Synergism | Drug Resistance, Neoplasm - genetics | Animals | ErbB Receptors - chemistry | Mutant Proteins - chemistry | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Thiazoles - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Protein Multimerization - drug effects | Drug Resistance, Neoplasm - drug effects | Studies | Phosphorylation | Nuclear magnetic resonance--NMR | Epidermal growth factor | Mutation | Kinases | Enzyme kinetics | Tumors
Journal Article
Nature, ISSN 0028-0836, 04/2015, Volume 520, Issue 7546, pp. 239 - 242
Non-small-cell lung cancer is the leading cause of cancer-related death worldwide(1). Chemotherapies such as the topoisomerase II (TopoII) inhibitor etoposide... 
ADENOCARCINOMA | MULTIDISCIPLINARY SCIENCES | COMPLEXES | SWI/SNF | GROWTH | GENE-EXPRESSION | ANTAGONISM | MUTATIONS | CANCER | POLYCOMB | MICROARRAY DATA | Polycomb Repressive Complex 2 - antagonists & inhibitors | Lung Neoplasms - drug therapy | Apoptosis - drug effects | Humans | Lung Neoplasms - pathology | Molecular Targeted Therapy | Antineoplastic Agents, Phytogenic - therapeutic use | Nuclear Proteins - genetics | DNA Helicases - genetics | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Carcinoma, Non-Small-Cell Lung - genetics | Genes, erbB-1 - genetics | Etoposide - pharmacology | Etoposide - therapeutic use | Topoisomerase II Inhibitors - pharmacology | Transcription Factors - genetics | Anaphase - drug effects | Enhancer of Zeste Homolog 2 Protein | Topoisomerase II Inhibitors - therapeutic use | Xenograft Model Antitumor Assays | Animals | Cell Line, Tumor | Mice | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Antineoplastic Agents, Phytogenic - pharmacology | Cell Cycle - drug effects | Protein research | Care and treatment | Oncology, Experimental | Genetic aspects | Research | Lung cancer, Non-small cell | Drug therapy | Gene expression | Cancer | Proteins | Genes | Lung cancer | Genetic engineering | Mutation | Kinases | Cancer therapies | Deoxyribonucleic acid--DNA | Tumors | Apoptosis | Etoposide | Chemotherapy | EZH2 inhibition | BRG1 | EGFR
Journal Article
Nature Genetics, ISSN 1061-4036, 09/2011, Volume 43, Issue 9, pp. 875 - 878
Journal Article
IEEE Transactions on Wireless Communications, ISSN 1536-1276, 11/2016, Volume 15, Issue 11, pp. 7272 - 7285
The energy consumption of a base station (BS) has attracted much attention in the study of wireless communication. Device-to-device communication, which can be... 
Wireless communication | Energy consumption | Base stations | Green cellular networks | device-to-device communication | Pricing | Interference | matching theory | adverse selection | Relays | Contracts | contract theory | TO-DEVICE COMMUNICATIONS | TELECOMMUNICATIONS | COGNITIVE RADIO NETWORKS | ENGINEERING, ELECTRICAL & ELECTRONIC | Matching | Algorithms | Traffic engineering
Journal Article
Nature, ISSN 0028-0836, 03/2012, Volume 483, Issue 7391, pp. 613 - 617
Targeted therapies have demonstrated efficacy against specific subsets of molecularly defined cancers(1-4). Although most patients with lung cancer are... 
SURVIVAL | VOLUME MEASUREMENT | GEFITINIB | ACTIVATION | METAANALYSIS | ADENOCARCINOMA | MULTIDISCIPLINARY SCIENCES | ARRY-142886 | STANDARDIZED UPTAKE VALUE | DOCETAXEL | MOUSE MODELS | Lung Neoplasms - drug therapy | Protein-Serine-Threonine Kinases - deficiency | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Lung Neoplasms - metabolism | ras Proteins - metabolism | Tomography, X-Ray Computed | Positron-Emission Tomography | Taxoids - therapeutic use | Biomarkers, Tumor - metabolism | Drug Evaluation, Preclinical | Benzimidazoles - therapeutic use | Disease Models, Animal | Proto-Oncogene Proteins p21(ras) - metabolism | Lung Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Pharmacogenetics - methods | Reproducibility of Results | Lung Neoplasms - enzymology | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Protein-Serine-Threonine Kinases - genetics | Antineoplastic Combined Chemotherapy Protocols | Proto-Oncogene Proteins - genetics | Treatment Outcome | Genes, p53 - genetics | Mutation - genetics | Randomized Controlled Trials as Topic | Animals | MAP Kinase Signaling System - drug effects | Benzimidazoles - pharmacology | Fluorodeoxyglucose F18 | Biomarkers, Tumor - genetics | Mice | Clinical Trials, Phase II as Topic | Antimitotic agents | Gene mutations | Genetic aspects | Dosage and administration | Research | Lung cancer, Non-small cell | Drug therapy | Antineoplastic agents | Health aspects | Confidence intervals | Hypotheses | Clinical trials | Tomography | Mutation | Pharmaceutical industry | Drug dosages | Cancer therapies | Patients | Tumors | Apoptosis
Journal Article
Computer, ISSN 0018-9162, 02/2016, Volume 49, Issue 2, pp. 54 - 62
Journal Article